Botfet / Company detail

EXEL

universe

Exelixis, Inc.

biotech

Moat score60out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic29.7%

Gross Margin96.4%

Revenue Cagr12.8%

Fcf Conversion107.9%

Fcf Yield5.2%

Interest Coverage0.0x

Market Cap B$16.3B

Pe19.6

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant60

Why it may endure

Moat breakdown

Quant: 60 · Curator: 0

Market Share Stability12

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener